Katharine A. Rendle, PhD, MSW, MPH
Associate Professor of Family Medicine and Community Health
Full Member, Abramson Cancer Center, Cancer Control Program
Senior Fellow, Leonard Davis Institute
Director of Cancer Implementation Research, Penn Implementation Science Center (PISCE)
Director, Penn Center for Cancer Care Innovation (PC3I), Abramson Cancer Center
Department: Family Medicine and Community Health
Graduate Group Affiliations
Contact information
Department of Family Medicine and Community Health
3600 Civic Center Blvd, 8th Floor
Philadelphia, PA 19104
3600 Civic Center Blvd, 8th Floor
Philadelphia, PA 19104
Office: 215-349-5442
Publications
Links
Search PubMed for articles
Penn Implementation Science Center at Leonard Davis Institute of Health Economics (PISCE@LDI)
Penn Center for Cancer Care Innovation
Search PubMed for articles
Penn Implementation Science Center at Leonard Davis Institute of Health Economics (PISCE@LDI)
Penn Center for Cancer Care Innovation
Education:
BA (Anthropology)
University of California, 2004.
MSW (Social Policy & Evaluation)
University of Michigan, 2007.
MA (Anthropology)
University of Michigan, 2008.
PhD (Social Work & Anthropology)
University of Michigan, 2014.
MPH (Epidemiology)
University of California, 2015.
Permanent linkBA (Anthropology)
University of California, 2004.
MSW (Social Policy & Evaluation)
University of Michigan, 2007.
MA (Anthropology)
University of Michigan, 2008.
PhD (Social Work & Anthropology)
University of Michigan, 2014.
MPH (Epidemiology)
University of California, 2015.
Description of Research Expertise
cancer prevention and care; healthcare delivery research; implementation science; mixed-methods research; clinical epidemiology; pragmatic trials; global healthSelected Publications
Kim RY, Gupta A, Ang L, Bilger A, Vachani A, Rendle KA.: Clinicians' cancer risk assessment among patients with pulmonary nodules: a qualitative study. Ann Am Thorac Soc 23: 458-463, Mar 2026.Pocobelli G, Del Vecchio NJ, Cushing-Haugen K, Kamineni A, Corley DA, Rendle KA, Halm EA, Li CI, Oshiro CES, Carroll NM, Silver MI, Greenlee RT, Neslund-Dudas C, Breslau ES, Chubak J.: Up-to-date prevalence at recommended ages for discontinuing routine colorectal, cervical and lung cancer screening. J Natl Cancer Inst Feb 2026.
Mehta SJ, Shaw PA, Reitz C, Brophy C, Okorie E, Williams K, Segura A, Tao J, Snider CK, Wollack C, Friday S, Rendle KA, Klaiman T, Glanz K, Rhodes C, Asch DA.: Sequential choice vs colonoscopy outreach for colorectal cancer screening: Design and rationale of a pragmatic randomized clinical trial. Contemp Clin Trials 2026.
Tortorello GN, Shafique N, De Jesus EM, Gimotty P, Dheer A, Fayanju OM, Tchou J, Miura JT, Karakousis GC, Rendle K.: Sentinel Lymph Node Biopsy in Low-Risk Breast Cancer in Patients ≥ 70 Years: How Wisely are We Choosing? Ann Surg Oncol 2026.
Wittner V, Purcell J, Cayabyab M, Hoffecker G, Kalman J, Teitelbaum U, Schnoll R, Rendle KA, Tuteja S.: Patient and provider perspectives on the implementation of DPYD testing in oncology care clinics in an academic health system. J Am Pharm Assoc (2003) 2026.
Halm EA, Del Vecchio NJ, Rendle KA, Tiro JA, Zheng Y, Winer RL, Haas JS, Corley DA, Skinner CS, Schottinger J, Ghai NR, Chubak J.: Longitudinal Adherence to Screening for Colorectal, Cervical, and Lung Cancer in a US Consortium. J Gen Intern Med Oct 2025.
MacDuffie E, McCallister C, George J, Monare B, Ketlametswe R, Ramontshonyana G, Mmari A, Pharithi M, Mntande L, Vuylsteke P, Bazzett-Matabele L, Kernell C, Hughes K, Kassick M, Bvochora-Nsingo M, Rendle KA, Grover S.: Assessing the impact of multidisciplinary team gynecological oncology care in Botswana: A potential model for low- and middle-income countries. Cancer 131: e70006, Aug 2025.
Aamodt WW, Eickholt L, Coughlin DG, Solomon L, Rendle KA, Marshall C, Vizcarra JA, Dahodwala N.: Sex and Racial/Ethnic Differences in End-of-Life Care Preferences in Persons with Parkinson's Disease and Related Disorders. Mov Disord May 2025.
Caruso CR, Kim RY, Rendle KA, Vachani A.: Evaluating the Nonmalignancy Rate in the National Lung Screening Trial: Addressing Surgical Misclassification. Chest May 2025.
Carroll NM, Eisenstein J, Wain KF, Freml JM, Greenlee RT, Honda SA, Neslund-Dudas C, Rendle KA, Vachani A, Ritzwoller DP.: Patterns of recurrence among adults diagnosed with screen-detected lung cancer. Cancer Epidemiol April 2025.